Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$615M |
| 2 |
Uber
UBER
|
+$551M |
| 3 |
Expedia Group
EXPE
|
+$523M |
| 4 |
PayPal
PYPL
|
+$452M |
| 5 |
Eaton
ETN
|
+$408M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$681M |
| 2 |
RTN
Raytheon Company
RTN
|
+$543M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$537M |
| 4 |
Charter Communications
CHTR
|
+$472M |
| 5 |
SPDR Gold Trust
GLD
|
+$464M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.29% |
| 2 | Financials | 4.55% |
| 3 | Industrials | 4.18% |
| 4 | Healthcare | 4.08% |
| 5 | Consumer Discretionary | 3.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
PUT
VeriSign
VRSN
$25.7B
| $6.13M | ﹤0.01% |
31,800
+3,800
| +14% | +$714K |
|
2677
PUT
Vanguard Morningstar Total Stock Market ETF
VTI
$695B
| $6.12M | ﹤0.01% |
37,400
+16,900
| +82% | +$2.65M |
|
2678
MGP Ingredients
MGPI
$379M
| $6.11M | ﹤0.01% |
126,171
+2,058
| +2% | +$96.4K |
|
|
PPL
2679
PUT
PPL Corp
PPL
$27.1B
| $6.11M | ﹤0.01% |
170,200
-19,700
| -10% | -$660K |
|
2680
Wolverine World Wide
WWW
$1.73B
| $6.1M | ﹤0.01% |
180,710
-44,645
| -20% | -$1.39M |
|
|
NPTN
2681
DELISTED
NEOPHOTONICS CORP
NPTN
| $6.09M | ﹤0.01% |
690,659
-355,364
| -34% | -$2.66M |
|
2682
EQT Corp
EQT
$34B
| $6.09M | ﹤0.01% |
558,463
-8,089,378
| -94% | -$79.1M |
|
2683
CALL
Iovance Biotherapeutics
IOVA
$3.16B
| $6.08M | ﹤0.01% |
219,800
-185,500
| -46% | -$4.22M |
|
2684
US Physical Therapy
USPH
$1.21B
| $6.07M | ﹤0.01% |
53,109
+22,821
| +75% | +$2.84M |
|
2685
ProShares Ultra Financials
UYG
$860M
| $6.07M | ﹤0.01% |
113,101
+31,309
| +38% | +$1.56M |
|
2686
CALL
iShares Russell 2000 Growth ETF
IWO
$15.2B
| $6.06M | ﹤0.01% |
28,300
+400
| +1% | +$81.2K |
|
2687
CALL
Live Nation Entertainment
LYV
$43.9B
| $6.06M | ﹤0.01% |
84,800
-28,800
| -25% | -$1.95M |
|
2688
CALL
CF Industries
CF
$17.9B
| $6.06M | ﹤0.01% |
126,900
-10,600
| -8% | -$496K |
|
|
ZUO
2689
DELISTED
Zuora, Inc.
ZUO
| $6.05M | ﹤0.01% |
422,461
+388,132
| +1,131% | +$5.69M |
|
|
MIC
2690
PUT
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $6.05M | ﹤0.01% |
141,300
-23,100
| -14% | -$954K |
|
2691
PUT
Infosys
INFY
$49B
| $6.05M | ﹤0.01% |
585,900
+13,800
| +2% | +$139K |
|
2692
Baytex Energy
BTE
$3.06B
| $6.04M | ﹤0.01% |
4,174,179
+1,302,607
| +45% | +$1.61M |
|
2693
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$629M
| $6.04M | ﹤0.01% |
5,256
-3,500
| -40% | -$3.14M |
|
2694
PUT
Howmet Aerospace
HWM
$115B
| $6.04M | ﹤0.01% |
256,106
-220,115
| -46% | -$4.92M |
|
2695
PUT
Equifax
EFX
$21.2B
| $6.04M | ﹤0.01% |
43,100
-7,200
| -14% | -$997K |
|
2696
Northwest Natural Holdings
NWN
$2.14B
| $6.03M | ﹤0.01% |
81,833
+72,537
| +780% | +$5.01M |
|
2697
CorVel
CRVL
$3.32B
| $6.03M | ﹤0.01% |
207,021
+51,276
| +33% | +$1.36M |
|
2698
PUT
Ollie's Bargain Outlet
OLLI
$4.62B
| $6.03M | ﹤0.01% |
92,300
-9,700
| -10% | -$614K |
|
2699
CALL
CRISPR Therapeutics
CRSP
$5.18B
| $6.02M | ﹤0.01% |
98,900
-8,400
| -8% | -$459K |
|
2700
Cannae Holdings
CNNE
$635M
| $6.01M | ﹤0.01% |
161,574
+40,729
| +34% | +$1.34M |
|
Similar funds
Ken Griffin's Q4 2019 Portfolio in Review
As of Q4 2019, Ken Griffin held 10,299 positions worth $230B, up 8.7% from $212B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin withdrew a net $8.18B in Q4 2019, closing 1,265 positions and reducing 4,117 holdings. Its most notable exit was Celgene Corp, an estimated $681M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.3% of assets, down from 5.4% a quarter earlier, followed by Financials and Industrials.
Against the trend, Ken Griffin opened a new position in Interxion Holding N.V. worth $83.9M.
- Ken Griffin's largest Q4 2019 buy was Interxion Holding N.V.: 1,000,931 shares worth $83.9M.
- Ken Griffin added most to Amazon in Q4 2019, an estimated $615M increase.
- Ken Griffin's biggest Q4 2019 reduction was Raytheon Company, cutting an estimated $543M.
- Ken Griffin fully exited Celgene Corp in Q4 2019, selling an estimated $681M.
- Ken Griffin's ten largest holdings make up 23% of its $230B portfolio in Q4 2019.
- Ken Griffin opened 1,220 new positions and closed 1,265 in Q4 2019.
- Ken Griffin's portfolio value rose 8.7% quarter-over-quarter to $230B.
Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.